Nearly a year into the Biden administration, Dr. Robert Califf has been nominated to return as FDA Commissioner – amidst a continuing pandemic and criticism of recent FDA decisions and messaging. What’s next for the FDA under Dr. Califf’s leadership?

Join us for the insights of Nancy Bradish Myers, president of Catalyst Healthcare Consulting and former Senior Strategic Advisor in the FDA Commissioner’s office.

Why did President Biden choose Dr. Califf over other candidates? What does his experience in the Obama administration tell us about what he will do in 2022? What is his vision for the FDA, and what will be his key priorities—internally, on COVID-19 reviews, on drug approvals, on regulating promotional messages? Will there be changes in other senior positions? What are White House and Congressional expectations for the FDA?

• Webinar: Friday, Jan 21, 2022, 12-1 p.m. ET 
• Faculty: Nancy Bradish Myers, president, Catalyst Healthcare Consulting
• Zoom link to be provided to registrants
• Tuition: Only $65 (from member companies) or $80 (from non-member companies)
• If uncertain on membership, please see our list of member companies.
• Online registration open now—see below.

Don’t miss this inside look at an agency with profound impact on our industry!

For further information, contact jbigelow@cohealthcom.org.